US5254582AExpiredUtility

Antitumor compositions and methods

61
Assignee: LILLY CO ELIPriority: Feb 5, 1992Filed: Feb 5, 1992Granted: Oct 19, 1993
Est. expiryFeb 5, 2012(expired)· nominal 20-yr term from priority
C07D 307/79A61P 35/00C07D 307/77
61
PatentIndex Score
9
Cited by
36
References
3
Claims

Abstract

This invention provides the use of N-[[(3,4-dichlorophenyl)amino]carbonyl]-2,3-dihydrobenzofuran-5-sulfonamide, and pharmaceutically acceptable salts thereof, in the treatment of susceptible neoplasms in mammals. This invention further provides the novel aforementioned compound and its pharmaceutical formulations.

Claims

exact text as granted — not AI-modified
We claim: 
     
       1. A method of treating susceptible neoplasms in mammals which comprises administering to a mammal in need of said treatment an effective amount for treating susceptible neoplasms of a compound of the formula ##STR7## or a pharmaceutically acceptable salt thereof. 
     
     
       2. A compound of the formula ##STR8## and pharmaceutically acceptable salts thereof. 
     
     
       3. A pharmaceutical formulation comprising an effective amount of a compound of the formula ##STR9## or a pharmaceutically acceptable salt thereof, in combination with a suitable pharmaceutical excipient.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.